Ultime notizie per Kodiak Sciences (NASDAQ:KOD) Azioni

Kodiak Sciences

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Kodiak Sciences Inc

Eastman Kodak Co

KODIAK COPPER CORP by KODIAK COPPER CORP.

Kodiak Copper Corp

Kodiak Energy Inc

Kodiak Gas Services Inc

Robert Kennedy Jr. has disclosed President-Elect Donald Trump&#8217;s three-fold directive to him, aimed at transforming the nation&#8217;s health landscape.
What Happened: On Wednesday, Kennedy Jr. took to X to share the tasks Trump has assigned to him. He wrote that Trump asked him to do three things: clean up corruption in health agencies, restore evidence-based science, and end the chronic disease epidemic to make America healthy again.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">President Trump has asked me to do three things: 1. Clean up the corruption in our government health agencies. 2. Return those agencies to their rich tradition of gold-standard, evidence-based science. 3. Make America Healthy Again by ending the chronic disease epidemic. <a href="https://t.co/WHMOsD0CiI">pic.twitter.com/WHMOsD0CiI</a>
&mdash; Robert F. Kennedy Jr (@RobertKennedyJr) <a href="https://twitter.com/RobertKennedyJr/status/1854281809464529384?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/large-cap/24/11/41741814/walgreens-agrees-to-100-million-settlement-over-alleged-deceptive-pricing-of-generic-drugs?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Walgreens Agrees To $100 Million Settlement Over Alleged Deceptive Pricing Of Generic Drugs</a>
This announcement comes after Trump&#8217;s previous pledge to give Kennedy <a href="https://www.benzinga.com/news/24/10/41565423/trump-says-robert-kennedy-jr-can-run-wild-on-health-and-food-im-going-to-let-him-go-wild-on-the-medi">full authority over health</a>, food, and medicine issues if he secures a second term. The former President had expressed his intent to allow Kennedy to &#8220;run wild&#8221; on these matters, with the exception of oil.
Kennedy Jr. is known for his contentious views on vaccines and has also been know to speak out regularly on food additives. In the aftermath of the election, shares of pharmaceutical companies, particularly those associated with the COVID-19 vaccine, have slid.
On Wednesday Pfizer Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and Modern Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) stocks hovered near their 52-week lows of $25.20 and $49.60 respectively. For the day, PFE ended 2.2% lower at $27.36, while MRNA dropped 2.8% to $51.81. The iShares U.S. Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHE#NYSE">IHE</a>) fell 0.5% to $68.39 in a similar period.
Why It Matters: Kennedy&#8217;s new role and the tasks assigned to him align with Trump&#8217;s earlier statements. In a recent interview, Trump showed tentative support for Kennedy&#8217;s plan to <a href="https://www.benzinga.com/news/24/11/41704387/robert-kennedy-jr-says-he-will-advise-all-us-water-systems-to-remove-fluoride-on-day-1-of-trump-admi">remove fluoride from water</a>, a move aimed at improving public health. Kennedy, known for his health-related advocacies, stated that his administration would encourage all U.S. water systems to eliminate fluoride on its first day in office.
Furthermore, Kennedy had previously disclosed that he might be appointed by Trump to select leaders for <a href="https://www.benzinga.com/news/24/09/40931166/robert-kennedy-jr-trump-wants-him-to-help-pick-cdc-fda-and-nih-leaders-unravel-the-capture-of-agenci">key public health agencies</a>, including the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health. This latest announcement seems to confirm his involvement in these agencies, marking a significant shift in the country&#8217;s health policies.
Image via Shutterstock
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

News

Health Care

Politics

General

iShares Dow Jones US Pharmaceuticals Index Fund

MRNA

Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.

STOCK MOVES UP OVER 4% ON DAY
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="696" height="829" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/06212242/Screen-Shot-2024-11-06-at-4.19.30-PM.png" alt="" class="wp-image-3023" style="width:auto;height:450px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/06212242/Screen-Shot-2024-11-06-at-4.19.30-PM.png 696w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/06212242/Screen-Shot-2024-11-06-at-4.19.30-PM-252x300.png 252w" sizes="(max-width: 696px) 100vw, 696px" /></figure>
First Citizens BancShares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:00 AM on November 6th, a significant trading signal occurred for First Citizens BancShares, Inc. as it demonstrated a Power Inflow at a price of $2171.52. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in FCNCA&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in FCNCA&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for FCNCA, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data are brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $2171.52. The returns on the High price ($2275.99) and Close price ($2266.39) after the Power Inflow were respectively 4.8% and 4.4%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case, the high of the day and close were very close but that is not always the case
Past Performance is Not Indicative of Future Results

Signals

Markets

Trading Ideas

FCNCA

Tradepulse Power Inflow Alert: First Citizens Bancshares Inc. Rises Over 100 Points After Signal

NDRA

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

SQQQ

Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) sees FY2024 sales of $2.650 billion-2.850 billion.

Guidance

Everus Construction Group Sees FY2024 Sales $2.650B-2.850B

Tapping into voters&#8217; dissatisfaction with the economy, among other issues, Donald Trump won the popular vote in the presidential <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">election</a> on Tuesday night. 
Meanwhile, bond traders on Wall Street dubbed &#8220;bond vigilantes&#8221; remain worried about long-term economic prospects under a Trump presidency.
What Are Bond Vigilantes?: A bond vigilante is an investor who protests against inflationary monetary or fiscal policies by selling bonds. This, in turn, increases bond yields which can force politicians&#8217; hand against inflationary policies.
Inflation necessitates increases in interest rates which erode the value of bonds.
Yields increased sharply during the Clinton administration during a period of concern over fiscal spending. The administration subsequently reduced the federal deficit, leading yields to recede.
The Trump Campaign: Trump&#8217;s 2024 campaign focused on populist economic policies, including high tariffs on imported goods and a possible elimination of the income tax. Experts say that Trump&#8217;s agenda would spur economic growth but would <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39131503/ex-treasury-secretary-larry-summers-warns-trumps-re-election-may-push-mortgage-rate">be highly inflationary</a>.
Trump ran on tax cuts in his 2016 election win and enacted the Tax Cuts and Jobs, which <a href="https://taxfoundation.org/blog/tcja-corporate-tax-economic-effects/">boosted</a> corporate investment but <a href="https://www.benzinga.com/government/24/06/39462030/trump-added-nearly-two-times-more-to-the-national-debt-than-biden-while-in-office-new-report">added $1.9 trillion</a> to the U.S. national debt.
If Trump follows through on his policy commitments — which could be likely with a solidly red Senate and a yet-to-be-called House of Representatives — the fiscal deficit will balloon.
The Bond Market Reacts: The bond market quickly reacted to Trump&#8217;s win. The benchmark 10-year Treasury yield rose to 4.479%, its highest mark since July.
Much of Trump&#8217;s win was already priced in by the markets —10-year yields are up over seven-tenths of a percentage point since early September.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41785495/us-treasuries-take-sharpest-plunge-in-a-year-ahead-of-fed-meeting-could-powell-adjust-stance-in-">US Treasuries Take Sharpest Plunge In A Year Ahead Of Fed Meeting: Could Powell Adjust Stance In Response To Trump?</a></li>
</ul>
This image was created using artificial intelligence MidJourney.

Bonds

Return Of The Bond Vigilante: Yields Skyrocket After Trump Win

Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. The company reported quarterly sales of $175.021 million which beat the analyst consensus estimate of $173.365 million by 0.96 percent. This is a 12.94 percent increase over sales of $154.967 million the same period last year.

Earnings

Earnings Beats

QTWO

Q2 Holdings Q3 2024 GAAP EPS $(0.20) Beats $(0.22) Estimate, Sales $175.021M Beat $173.365M Estimate

Liberty Latin America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILAK#NASDAQ">LILAK</a>) reported quarterly losses of $(2.22) per share. The company reported quarterly sales of $1.089 billion which missed the analyst consensus estimate of $1.126 billion by 3.29 percent. This is a 3.29 percent decrease over sales of $1.126 billion the same period last year.

Earnings Misses

LILAK

Liberty Latin America Q3 2024 GAAP EPS $(2.22), Sales $1.089B Miss $1.126B Estimate

In the aftermath of the 2024 presidential election, Sen. Bernie Sanders (I-Vt.) has publicly criticized the Democratic Party&#8217;s handling of working-class issues.
What Happened: A statement released on Tuesday by Sanders expressed his disappointment with the Democratic Party&#8217;s neglect of the working class, which he believes has led to their abandonment of the party. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It should come as no great surprise that a Democratic Party which has abandoned working class people would find that the working class has abandoned them. While the Democratic leadership defends the status quo, the American people are angry and want change. And they're right. <a href="https://t.co/lM2gSJmQFL">pic.twitter.com/lM2gSJmQFL</a>
&mdash; Bernie Sanders (@BernieSanders) <a href="https://twitter.com/BernieSanders/status/1854271157135941698?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;It should come as no great surprise that a Democratic Party which has abandoned working class people would find that the working class has abandoned them.&#8221;
Sanders highlighted the increasing income and wealth inequality in the U.S., with 60% of Americans living paycheck to paycheck. He also criticized the country&#8217;s healthcare system and its continued financial support for the Netanyahu government.
&#8220;Unbelievably, real, inflation-accounted-for weekly wages for the average American worker are actually lower now than they were 50 years ago.&#8221;
Sanders wondered if the Democratic party would actually learn any real lessons from this &#8220;disastrous campaign.&#8221; He expressed his lack of confidence in this being a learning movement for the democrats.
&#8220;In the coming weeks and months those of us concerned about grassroots democracy and economic justice need to have some very serious political discussions,&#8221; said Sanders.
In a post on X, on Wednesday, Sanders said, &#8220;While the Democratic leadership defends the status quo, the American people are angry and want change.&#8221; He said &#8220;They&#8217;re right.&#8221;
See Also: <a href="https://www.benzinga.com/news/24/11/41733899/trump-woos-muslim-voters-says-hes-building-the-biggest-and-broadest-peace-coalition-kamala-and-her-w?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Woos Muslim Voters, Says He&#8217;s &#8216;Building The Biggest And Broadest&#8217; Peace Coalition: &#8216;Kamala And Her</a>
Why It Matters: Sanders&#8217; criticism comes in the wake of the 2024 presidential election, where Donald Trump <a href="https://www.benzinga.com/markets/asia/24/11/41768811/donald-trump-wins-47th-presidency-us-futures-up-europe-up-asia-mixed-crude-falls-and-dollar-strength">won over Democratic rival</a> Kamala Harris. The election results sparked an &#8220;everything rally&#8221; on Wall Street, with major U.S. equity indices surging to record highs. This was largely due to investor optimism over anticipated favorable tax policies under the Trump administration.
Before the election, Sanders had <a href="https://www.benzinga.com/news/24/10/41642184/bernie-sanders-says-trumps-plan-to-eliminate-all-income-taxes-is-insane-economics-will-trigger-the-b">criticized Trump&#8217;s proposal to eliminate all income taxes</a>, describing it as &#8216;insane economics&#8217; that would disproportionately benefit the wealthy. He also <a href="https://www.benzinga.com/news/24/10/41590597/bernie-sanders-explains-why-he-will-vote-for-kamala-harris-even-though-he-disagrees-with-her-stance">expressed his disagreement with Kamala Harris&#8217; stance on the Gaza war</a>, but still pledged his vote for her.
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Bernie Sanders Says 'American People Are Angry And Want Change' And 'They're Right' — Democrats Have Abandoned The Working Classes

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABUS#NASDAQ">ABUS</a>) with a Buy and raises the price target from $4 to $4.5.

Price Target

Analyst Ratings

ABUS

Chardan Capital Maintains Buy on Arbutus Biopharma, Raises Price Target to $4.5

Hurricane Rafael made landfall in Cuba as a Category 3 storm on Wednesday. Here's a look at what stocks could be affected as the hurricane takes <a href="https://www.benzinga.com/markets/equities/24/10/41240852/back-to-back-hurricanes-batter-floridas-insurance-market-stocks-to-watch">aim at the Gulf of Mexico. </a>
What To Know: According to <a href="https://www.foxweather.com/weather-news/tracking-hurricane-rafael-us-gulf-of-mexico-caribbean">a report</a> from Fox Weather, Hurricane Rafael made landfall in the Cuban province of Artemisa with sustained winds of 115 miles per hour, making it a Category 3 hurricane. The storm is expected to enter the Gulf of Mexico on Wednesday night and residents along the coast from Florida to Texas will be watching the storm's path.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
What To Watch: Hurricanes affect people, homes and companies in their paths and spread wide-reaching effects on various sectors and industries. Insurance companies see an influx of claims resulting from damage to property and vehicles. Homes will have to be repaired and rebuilt driving sales of lumber, windows and sheetrock higher. Power outages cause consumers to seek portable generators as an alternative way to power their homes.&nbsp;
Home improvement stores like Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) and Lowe&#8217;s Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) could see a pop in sales as people rush to secure their homes before the storm and repair damage after. 
Generac Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) designs and manufactures standby generators and portable generators and often sees its shares rise before and after major weather events. 
Shares of insurance companies tend to drop after natural disasters and investors may want to keep an eye on Allstate Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>), Travelers Companies, Inc.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) and Chubb Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) in the days and weeks following a potential landfall from Hurricane Rafael. 
Power companies including Duke Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) and Southern Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>) could face increased labor costs and additional costs to repair infrastructure after the storm.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a></li>
</ul>
Photo: Hurricane Rafael as a tropical storm, 11.5.2024. Courtesy the NOAA/Public Domain

GNRC

Hurricane Rafael Hits Cuba As Category 3 Storm: Stocks To Watch As Storm Heads Into Gulf Of Mexico

Jones Trading analyst Matthew Erdner maintains Angel Oak Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) with a Buy and maintains $12.5 price target.

AOMR

Jones Trading Maintains Buy on Angel Oak Mortgage REIT, Maintains $12.5 Price Target

ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) shares were down 2.22% to $661.43 at market close Wednesday following news of Donald Trump's victory in the <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">2024 U.S. presidential election</a>.
Trump&#8217;s return to office, coupled with a Republican majority in the Senate and a lead in the House of Representatives, has raised concerns over renewed trade tensions and the possibility of aggressive tariffs.
What To Know: During his campaign, Trump proposed a 60% tariff on Chinese goods, along with a universal 10% tariff on all imports to the U.S. This policy direction is worrying for global technology companies, including ASML, as its advanced lithography machines are essential to semiconductor production worldwide.
ASML's products are already impacted by U.S.-China trade policies, given the semiconductor industry's reliance on complex international supply chains. ASML, which is headquartered in the Netherlands, sells its equipment globally, including to Chinese companies — a significant revenue stream now facing increased uncertainty.
Read Also: <a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different">How Did S&amp;P 500 Sectors Perform During Trump&#8217;s First Term? Could This Time Be Different?</a>
What Else: The potential for additional restrictions on U.S. companies doing business with Chinese firms under Trump's administration could also hurt ASML's business indirectly. If U.S.-based tech giants face hurdles in the Chinese market, their demand for advanced lithography machines from ASML may diminish. 
Additionally, rising economic and political tensions could fuel an ongoing shift in tech supply chains as companies reassess global expansion plans and sourcing, a trend that could complicate ASML's growth strategy over the long term.
Market analysts at JPMorgan Chase &amp; Co underscored Trump's proposed tariffs are likely to be "a direct headwind to global technology trade," which could hit companies like ASML more acutely than other sectors.
Given ASML's reliance on global market stability and free trade to maintain its dominance in semiconductor manufacturing equipment, the return of protectionist trade policies under Trump's administration raises significant concerns about the company's medium- to long-term outlook.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ASML has a 52-week high of $1,110.09 and a 52-week low of $633.80.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784504/trumps-win-sends-indices-to-record-highs-financials-small-caps-surge-bitcoin-tops-75-000-w">Trump&#8217;s Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What&#8217;s Driving Markets Wednesday?</a></li>
</ul>
Photo: Shutterstock

Global

Movers

Tech

ASML

What's Going On With ASML Holding Stock?

Usio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USIO#NASDAQ">USIO</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.01 by 300 percent. The company reported quarterly sales of $21.321 million which missed the analyst consensus estimate of $21.384 million by 0.29 percent. This is a 3.90 percent increase over sales of $20.520 million the same period last year.

USIO

Usio Q3 2024 Adj. EPS $(0.02) Misses $0.01 Estimate, Sales $21.321M Miss $21.384M Estimate

TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $46.544 million which beat the analyst consensus estimate of $44.856 million by 3.76 percent. This is a 13.12 percent increase over sales of $41.146 million the same period last year.

TRUE

TrueCar Q3 2024 GAAP EPS $(0.06), Inline, Sales $46.544M Beat $44.856M Estimate

ChargePoint Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) shares closed Wednesday down 17.01% to $1.22. Electric vehicle-related stocks are trading lower after Donald Trump won the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784504/trumps-win-sends-indices-to-record-highs-financials-small-caps-surge-bitcoin-tops-75-000-w">2024 presidential election</a>. Investors may be weighing future policy-making decisions that could impact the industry.
Trump&#8217;s return to office, alongside a Republican-controlled Senate and a leading position in the House of Representatives, signals a sharp pivot away from the climate-focused policies pursued by the Biden-Harris administration. 
What To Know: Investors are reacting to fears that Trump's proposed policy shifts could undermine the EV sector, including infrastructure developments crucial to ChargePoint's business model.
Throughout his campaign, Trump made it clear that he intends to roll back green energy subsidies and incentives that have been key to the growth of EV infrastructure. His tax policy agenda includes rescinding federal tax credits for green energy projects, a move expected to slow the pace of EV adoption as it would make EVs more expensive for consumers.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41782783/coinbase-ceo-brian-armstrong-welcomes-most-pro-crypto-congress-ever-as-end-to-gary-gensler">Coinbase CEO Brian Armstrong Welcomes &#8216;Most Pro-Crypto Congress Ever,&#8217; As End To Gary Gensler&#8217;s SEC Chair Stint Nears</a>
Under the Biden administration, the EV market benefited from substantial federal support, including charging infrastructure tax credits and rebates that have helped ChargePoint expand its network and accelerate growth. 
Trump&#8217;s proposed cuts to these initiatives raise questions about the future demand for charging stations, a primary revenue driver for ChargePoint.
What Else: Analysts are also concerned about the impact of Trump's proposed tariffs and trade policies on the EV industry. Trump's plan to impose a universal 10% tariff on all imports, alongside a 60% tariff on Chinese goods, could increase costs for manufacturers and suppliers in the EV supply chain, as many EV components, such as batteries, are still sourced internationally. 
For ChargePoint, which relies on a global supply chain for equipment and infrastructure, these tariffs could increase costs, squeeze margins and limit the availability of critical components, potentially delaying installations. Higher tariffs could also drive up prices for EVs, reducing consumer demand, and further suppressing the market for charging networks.
<h1 class="wp-block-heading">Should I Sell My CHPT Stock?</h1>
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
Shares of ChargePoint have decreased by 55.29% in the past year. An investor who bought shares of ChargePoint at the beginning of the year would take a loss of $0.94 per share if it was sold today. The stock has fallen 11.87% over the past month, meaning an investor who bought shares on Oct. 1 would see a capital loss of $0.08.
Investors may also consider market dynamics. The Relative Strength Index can indicate whether a stock is overbought or oversold. ChargePoint stock currently has an RSI of 75.68, indicating overbought conditions.
For access to advanced charting and analysis tools and stock data, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
ChargePoint has a 52-week high of $3.54 and a 52-week low of $1.20.
Read Also: • <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41783773/the-future-of-crypto-regulation-under-a-trump-administration-headwinds-are-now-tailwinds">The Future Of Crypto Regulation Under A Trump Administration: &#8216;Headwinds Are Now Tailwinds&#8217;</a>
Photo: Courtesy ChargePoint

CHPT

Here's Why ChargePoint Stock Is Under Pressure

Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.42) by 7.14 percent. The company reported quarterly sales of $28.666 million which beat the analyst consensus estimate of $26.905 million by 6.55 percent. This is a 5.59 percent decrease over sales of $30.362 million the same period last year.

Outset Medical Q3 2024 Adj. EPS $(0.39) Beats $(0.42) Estimate, Sales $28.666M Beat $26.905M Estimate

Following Donald Trump's presidential <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">election victory Tuesday</a>, the cannabis sector took a sharp downturn.
Here's a summary of the largest stock declines across the industry based on<a href="https://www.benzinga.com/pro/"> data from Benzinga Pro</a>. 
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Top Cannabis Stocks And ETFs Facing Major Losses Post-Election</h3>
<ul>
<li>Trulieve Cannabis (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNFF#OTC">TCNFF</a>): Closed at $7.136, down $5.564 (-43.81%). Volume: 3,590,905 shares.</li>
<li>Cansortium (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>): Ended at $0.09803, falling $0.058 (-37.16%). Volume: 2,226,672 shares.</li>
<li>AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>): Closed at $4.935, down $1.935 (-28.17%). Volume: 35,572,290 shares.</li>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): Closed at $2.23, down $0.884 (-28.39%). Volume: 3,072,876 shares.</li>
<li>Cresco Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>): Ended at $1.1342, dropping $0.3958 (-25.87%). Volume: 3,163,255 shares.</li>
<li>C21 Investments (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>): Closed at $0.17, down $0.0536 (-23.97%). Volume: 218,362 shares.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): Closed at $4.285, losing $1.305 (-23.35%). Volume: 10,958,783 shares.</li>
<li>Scotts Miracle-Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>): Closed at $74.46, falling $19.01 (-20.34%). Volume: 2,562,247 shares.</li>
<li>Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>): Finished at $8.61, down $2.07 (-19.38%). Volume: 2,503,233 shares.</li>
<li>Amplify Alternative Harvest ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MJ#NYSE">MJ</a>): Closed at $2.71, down $0.61 (-18.37%). Volume: 3,404,675 shares.</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>): Closed at $5.01, down $1.10 (-18.00%). Volume: 3,702,665 shares.</li>
<li>Jushi Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/JUSHF#OTC">JUSHF</a>): Closed at $0.391, down $0.0753 (-16.15%). Volume: 587,553 shares.</li>
<li>AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>): Closed at $2.7896, down $0.5304 (-15.98%). Volume: 314,508 shares.</li>
<li>Vext Science (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VEXTF#OTC">VEXTF</a>): Closed at $0.1165, down $0.021 (-15.27%). Volume: 379,172 shares.</li>
<li>SNDL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>): Closed at $2.035, down $0.355 (-14.85%). Volume: 6,016,260 shares.</li>
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>): Closed at $1.52, down $0.25 (-14.12%). Volume: 45,915,711 shares.</li>
<li>Medical Marijuana Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>): Closed at $0.0007, down $0.0001 (-12.5%). Volume: 25,466,093 shares.</li>
<li>OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>): Closed at $1.675, down $0.175 (-9.46%). Volume: 1,274,063 shares.</li>
<li>Village Farms International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>): Closed at $0.8332, down $0.0659 (-7.33%). Volume: 1,133,165 shares.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/11/41792417/cannabis-reit-giant-iipr-reports-q3-39-7m-profit-despite-rent-delays-in-sector">Cannabis REIT Giant IIPR Reports Q3 $39.7M Profit Despite Rent Delays In Sector</a>

Cannabis

Sector ETFs

ETFs

CNTMF

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CXXIF

GTBIF

JUSHI HLDGS INC CL B by Jushi Holdings Inc.

JUSHF

MJNA

MSOS

SNDL

TCNFF

TLRY

VEXTF

YOLO

Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close

The U.S. election results have stirred up first reactions in the markets. Analysts from JPMorgan Chase &amp; Co see Donald Trump&#8217;s return to the White House as a potential shift in the <a href="https://www.benzinga.com/markets/commodities">commodity market</a>.
The bank&#8217;s equity research analyst, Bill Peterson, noted Trump&#8217;s history of deregulation and tariff-heavy policies, suggesting that this approach could lead to greater domestic support for the U.S. steel industry.
&#8220;We expect a broad-based positive knee-jerk reaction for steel equities," Peterson said in a note, pointing to the likely impact of more tariffs on Chinese and Mexican steel. In contrast, metals closely tied to the Chinese market, such as copper, may face downward pressure due to heightened U.S.-China trade tensions.
United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) shares closed the day rallying over 8%. 
Concerns about tariffs are particularly high in Canada, where Toronto's commodity-heavy market is sensitive to U.S. economic policy. The Toronto Stock Exchange's materials sector has already felt the impact, with GreenFirst Forest Products (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ICLTF#OTC">ICLTF</a>) closing Wednesday down 3.40%.
While the U.S. dollar had periods of decoupling from its typically inverse correlation to commodity prices, that was not the case following the election results.
&#8220;A strong U.S. dollar has somewhat weighed on commodity prices," Douglas Porter, chief economist at BMO Capital Markets, said <a href="https://www.reuters.com/markets/tsx-futures-surge-more-than-1-after-trumps-election-victory-2024-11-06/">per</a> Reuters.
Notably, Porter was one of the voices pointing out the elephant in the room: the budget deficit issue. 
"The reality is that neither presidential candidate has offered any serious path to reining in the budget deficit — quite the opposite for the most part," he <a href="https://economics.bmo.com/en/publications/detail/8f1107e4-aca6-4249-8b06-e7f638059877/">wrote</a> in September.
Porter&#8217;s current insight reflects a broader worry that if Trump imposes aggressive tariffs, the Canadian market's reliance on resource exports could be at risk, impacting commodity-driven industries across North America.
Over his first term, Trump has consistently supported the U.S. mining sector. In 2020, he issued an executive order backing critical mineral mining, stating, "A strong America cannot be dependent on imports from foreign adversaries for the critical minerals necessary to maintain our economic and military strength."
Trump&#8217;s 25% tariff on imported steel and 10% on aluminum from 2018 was eventually revoked by the Biden administration.
Trump's emphasis on "American independence" in mining could signal more federal backing for domestic projects if he pursues similar policies in his second term.
Still, experts warn about the necessity from the demand side.
"There's not actually much being done on the demand side to make sure that these products are going to have an off-taker," said John Jacobs, a senior policy analyst at the Bipartisan Policy Center <a href="https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/trump-harris-back-mining-but-producers-unsatisfied-83216353">per</a> S&amp;P Global.
Yet, the mining issue might be too complex for any administration to address over a single term. Currently, there are no operational U.S. mines focused on essential battery metals like cobalt or graphite and only one active nickel mine.
Read Next: • <a href="https://www.benzinga.com/markets/equities/24/11/41785495/us-treasuries-take-sharpest-plunge-in-a-year-ahead-of-fed-meeting-could-powell-adjust-stance-in-">US Treasuries Take Sharpest Plunge In A Year Ahead Of Fed Meeting: Could Powell Adjust Stance In Response To Trump?</a>
Photo by QinJin on Shutterstock

Commodities

ICLTF

Trump's Victory A Tailwind For Domestic Steel, Risk For Canada, Say Analysts

MariMed (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) raises FY2024 sales outlook from $156.03 million-159.00 million to $157.51 million-160.49 million.

MRMD

MariMed Raises FY2024 Sales Guidance from $156.03M-159.00M to $157.51M-160.49M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Kodiak Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/kod-stock-quote/">KOD</a>) just reported results for the first quarter of 2024.<ul><li>Kodiak Sciences reported earnings per share of -82 cents. This was above the analyst estimate for EPS of -$1.07.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/kod-stock-earnings-kodiak-sciences-for-q1-of-2024/">KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024

Barclays analyst Gena Wang maintained a Sell rating on Kodiak Sciences (KOD – Research Report) today and set a price target of $3.00. The company's...

Kodiak Sciences (KOD) Receives a Sell from Barclays

Tracking Baker Brothers Portfolio - Q1 2024 Update

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Kodiak Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/kod-stock-quote/">KOD</a>) just reported results for the second quarter of 2024.<ul><li>Kodiak Sciences reported earnings per share of -86 cents. This was above the analyst estimate for EPS of -$1.19.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/kod-stock-earnings-kodiak-sciences-for-q2-of-2024/">KOD Stock Earnings: Kodiak Sciences Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KOD Stock Earnings: Kodiak Sciences Beats EPS for Q2 2024

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kodiak Sciences (KOD – Research Report) and Pro Medicus Limited (...

Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD) and Pro Medicus Limited (OtherPMCUF)

Matthew Caufield, an analyst from H.C. Wainwright, has initiated a new Hold rating on Kodiak Sciences (KOD). Matthew Caufield has given his Hold ra...

Evaluating Kodiak Sciences: A Hold Rating Amidst Clinical Setbacks and Competitive Pressures

Tracking Baker Brothers Portfolio - Q2 2024 Update

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biohaven Ltd. (BHVN – Research Report) and Kodiak Sciences (KOD –...

Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN) and Kodiak Sciences (KOD)

Barclays analyst Gena Wang assigned a Sell rating to Kodiak Sciences (KOD – Research Report) today and set a price target of $3.00. The company's s...

Barclays Releases a Sell Rating on Kodiak Sciences (KOD)

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Kodiak Sciences (KOD – Research Report). The company's shares ...

Evercore ISI Keeps Their Buy Rating on Kodiak Sciences (KOD)

ABBV

ABCL

ACAD

AKRO

ARGNF

ARGX

BCRX

BCYC

BEIGF

BGNE

BHVN

BMYMP

CERE

DNLI

EWTX

IMCR

IMTX

IMTXW

INCY

INSM

KYMR

MDGL

PMCUF

RARE

REPL

ROIV

RVMD

RVMDW

RYTM

TRDA

Press Releases

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

Comments

Kodiak Sciences

Notizie

Ultime notizie per Kodiak Sciences (NASDAQ:KOD) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO